NasdaqGS - Nasdaq Real Time Price USD

Apyx Medical Corporation (APYX)

Compare

1.8500

+0.0100

(+0.54%)

At close: December 11 at 4:00:01 PM EST

1.8107

-0.04

(-2.12%)

After hours: December 11 at 4:09:12 PM EST

Why Is Apyx Medical Corporation (APYX) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now?

We recently compiled a list of the 11 Best Cosmetic Surgery and Aesthetics Stocks to Invest in Now. In this article, we are going to take a look at where Apyx Medical Corporation (NASDAQ:APYX) stands against the other cosmetic surgery and aesthetics stocks. In the face of economic uncertainty, consumer preferences in the beauty industry are […]

Insider Monkey yesterday

APYX
+0.54%
Calculating The Intrinsic Value Of Apyx Medical Corporation (NASDAQ:APYX)

Key Insights The projected fair value for Apyx Medical is US$1.56 based on 2 Stage Free Cash Flow to Equity With...

Simply Wall St. 3 days ago

APYX
+0.54%
Apyx Medical Corporation to Participate in the Piper Sandler 36th Annual Healthcare Conference

CLEARWATER, Fla., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, today announced that management will participate in the Piper Sandler 36th Annual Healthcare Conference on Wednesday, December 4, 2024, in New York, NY. Charlie Goodwin, the Company’s President and Chief Executive Officer, and Matt Hill, the Company’s Chief

GlobeNewswire 14 days ago

APYX
+0.54%
Apyx Medical Corporation to Attend 15th Annual Craig-Hallum Alpha Select Conference

CLEARWATER, Fla., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, today announced that Charles Goodwin, President and CEO and Matt Hill, CFO will be attending the following upcoming conference: Event: 15th Annual Craig-Hallum Alpha Select ConferenceDate: November 19, 2024Location: Sheraton NY Times Square Hotel, New York,

GlobeNewswire 29 days ago

APYX
+0.54%
Apyx Medical Third Quarter 2024 Earnings: EPS Beats Expectations

Apyx Medical ( NASDAQ:APYX ) Third Quarter 2024 Results Key Financial Results Revenue: US$11.5m (down 4.1% from 3Q...

Simply Wall St. last month

APYX
+0.54%
Apyx Medical Corp (APYX) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ...

Despite a revenue dip, Apyx Medical Corp (APYX) focuses on growth through new product development and strategic investments.

GuruFocus.com last month

APYX
+0.54%
Apyx Medical (APYX) Reports Q3 Loss, Lags Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of 6.67% and 1.48%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks last month

APYX
+0.54%
BRBR
Apyx: Q3 Earnings Snapshot

CLEARWATER, Fla. AP) — Apyx Medical Corporation (APYX) on Friday reported a loss of $4.7 million in its third quarter. On a per-share basis, the Clearwater, Florida-based company said it had a loss of 14 cents.

Associated Press Finance last month

APYX
+0.54%
Apyx Medical Corporation Announces $7,000,000 Million Registered Direct Offering

CLEARWATER, Fla., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical” or the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, today announced it has entered into a definitive purchase agreement with Nantahala Capital for the purchase and sale in a registered direct offering of 3,000,000 shares of the Company’s common stock at a purchase price of $1.18 per share and pre-funded wa

GlobeNewswire last month

APYX
+0.54%
Apyx Medical Corporation Reports Third Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook and Introduces Full Year 2025 Financial Outlook

Strengthened balance sheet with a common stock registered direct offering with gross proceeds of approximately $7.0 million; and amended revenue covenants for the Company’s credit agreement with PerceptiveAnnounces cost savings restructuring program to better focus, optimize and streamline operations, including a nearly 25% reduction in U.S. workforce Announces 9% overall growth in single-use handpiece revenue and 15% growth in the U.S.Management to host a conference call today at 8:00 a.m. ET C

GlobeNewswire last month

APYX
+0.54%
Apyx Medical Corporation to Release Third Quarter Of Fiscal Year 2024 Financial Results on November 8, 2024

CLEARWATER, Fla., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Apyx® Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, today announced that financial results for the third quarter of fiscal year 2024 will be released before the market opens on Friday, November 8th. Management will host a conference call at 8:00 a.m. Eastern Time on November 8th to discuss the results of th

GlobeNewswire last month

APYX
+0.54%
Chuck Royce's Strategic Acquisition of Apyx Medical Corp Shares

On September 30, 2024, the investment firm managed by Chuck Royce (Trades, Portfolio) reported a significant addition to its portfolio by acquiring 85,267 shares of Apyx Medical Corp (NASDAQ:APYX), a notable player in the medical devices sector. Charles M. Royce, a venerated figure in the investment community, has been at the helm of Royce Pennsylvania Mutual Fund since 1972. With a robust educational background from Brown University and an MBA from Columbia University, Royce has carved a niche in small-cap investing.

GuruFocus.com last month

APYX
+0.54%
Apyx Medical Corp (APYX) Q2 2024 Earnings Call Highlights: Navigating Revenue Declines and ...

Despite a challenging quarter with a 10% revenue drop, Apyx Medical Corp (APYX) focuses on OEM growth and expanding market presence.

GuruFocus.com 2 months ago

APYX
+0.54%
Apyx (APYX) Upgraded to Buy: Here's What You Should Know

Apyx (APYX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks 2 months ago

APYX
+0.54%
Apyx Medical Insiders Placed Bullish Bets Worth US$2.27m

Quite a few insiders have dramatically grown their holdings in Apyx Medical Corporation ( NASDAQ:APYX ) over the past...

Simply Wall St. 3 months ago

APYX
+0.54%
Renuvion Named #1 Trusted Body Contouring Technology by Doctors*

Apyx® Medical Corporation (NASDAQ: APYX) ("Apyx Medical;" the "Company"), a leader in advanced energy technology and the manufacturer of Renuvion®, today announced that doctors named Renuvion as the #1 trusted body contouring technology in an independent survey by Wakefield Research.** This recognition underscores the effectiveness of Renuvion's novel technology that targets loose skin at the source, offering unparalleled results for body contouring procedures.

PR Newswire 3 months ago

APYX
+0.54%
Apyx Medical (APYX) Reports Q2 Loss, Lags Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of -5.56% and 4.11%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 4 months ago

APYX
+0.54%
Apyx: Q2 Earnings Snapshot

CLEARWATER, Fla. AP) — Apyx Medical Corporation (APYX) on Thursday reported a loss of $6.6 million in its second quarter. The Clearwater, Florida-based company said it had a loss of 19 cents per share.

Associated Press Finance 4 months ago

APYX
+0.54%
Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Comparing the Use of Renuvion to a Competing Technology Following Liposuction or Body Contouring Procedures

CLEARWATER, Fla., August 08, 2024--Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical"; the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, today announced the publication of a peer-reviewed article in the journal, Plastic and Reconstructive Surgery—Global Open, featuring the results of study which compared the use of Renuvion’s Helium Plasma Technology to InMode’s Bipolar RF System ("Bipolar RF") following lip

Business Wire 4 months ago

APYX
+0.54%
Apyx Medical Corporation Reports Second Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook

CLEARWATER, Fla., August 08, 2024--Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical;" the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, today reported financial results for its second quarter ended June 30, 2024; and updated its financial expectations for the full year ending December 31, 2024.

Business Wire 4 months ago

APYX
+0.54%

Performance Overview

Return	APYX	S&P 500
YTD	-29.39%	+27.56%
1-Year	-12.74%	+32.14%
3-Year	-86.12%	+29.12%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Apyx Medical Corporation (APYX)

Why Is Apyx Medical Corporation (APYX) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now?

Calculating The Intrinsic Value Of Apyx Medical Corporation (NASDAQ:APYX)

Apyx Medical Corporation to Participate in the Piper Sandler 36th Annual Healthcare Conference

Apyx Medical Corporation to Attend 15th Annual Craig-Hallum Alpha Select Conference

Apyx Medical Third Quarter 2024 Earnings: EPS Beats Expectations

Apyx Medical Corp (APYX) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ...

Apyx Medical (APYX) Reports Q3 Loss, Lags Revenue Estimates

Apyx: Q3 Earnings Snapshot

Apyx Medical Corporation Announces $7,000,000 Million Registered Direct Offering

Apyx Medical Corporation Reports Third Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook and Introduces Full Year 2025 Financial Outlook

Apyx Medical Corporation to Release Third Quarter Of Fiscal Year 2024 Financial Results on November 8, 2024

Chuck Royce's Strategic Acquisition of Apyx Medical Corp Shares

Apyx Medical Corp (APYX) Q2 2024 Earnings Call Highlights: Navigating Revenue Declines and ...

Apyx (APYX) Upgraded to Buy: Here's What You Should Know

Apyx Medical Insiders Placed Bullish Bets Worth US$2.27m

Renuvion Named #1 Trusted Body Contouring Technology by Doctors*

Apyx Medical (APYX) Reports Q2 Loss, Lags Revenue Estimates

Apyx: Q2 Earnings Snapshot

Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Comparing the Use of Renuvion to a Competing Technology Following Liposuction or Body Contouring Procedures

Apyx Medical Corporation Reports Second Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook

Performance Overview